Discover 1,024 paid clinical trials in Saint Paul, Minnesota. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,024
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Location: Maplewood MN, Grand Rapids MI, Westwood KS, Detroit MI,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT05579366
Phase 1, Phase 2, Recruiting
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
for
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer,
Location: Maplewood MN, Sioux Falls SD, Grand Rapids MI,
Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Sex: Female
Age: 18+
Code: NCT05128825
Phase 2, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Maplewood MN, Minneapolis MN, Saint Louis Park MN,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase 3, Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
for
Atrial Fibrillation (AF)
Location: Maplewood MN, Merrillville IN, Flint MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07175428
Phase 2, Recruiting
New
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Maplewood MN, Cullman AL, Bradenton FL
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07881757
Phase 3, Recruiting
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
for
Pulmonary Disease, Chronic Obstructive
Location: Maplewood MN, Westchester IL, Indianapolis IN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 40 - 70+
Code: NCT07759245
Phase 2, Recruiting
A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
for
Apnea, Sleep Disorders, Overweight and/or Obesity
Location: Maplewood MN, Little Rock AR, Cullman AL, Dallas TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07823608
Phase 3, Recruiting
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
for
Breast Cancer
Location: Saint Paul MN, Des Moines IA, Chicago IL, St Louis MO,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06103864
Phase 3, Recruiting
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
for
Sepsis, Acute Infection, Organ Failure
Location: Maplewood MN, Minneapolis MN, Edina MN, Burnsville MN,
Sponsor: University of Minnesota
Sex: All
Age: 65+
Code: NCT05758246
Phase 2, Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Maplewood MN, Minneapolis MN, Edina MN, Burnsville MN,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase 3, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma